cervical dystonia


Also found in: Medical, Encyclopedia, Wikipedia.
Related to cervical dystonia: Cervical dysplasia
Translations

cervical dystonia

n. distonia cervical, trastorno de tonicidad en los tejidos de la nuca que resulta en incapacitación de movimiento voluntario del cuello.
References in periodicals archive ?
Additional XEOMIN poster presentations at the AAN Annual Meeting will report data regarding injection intervals in the treatment of cervical dystonia and blepharospasm.
In its update to the early communication and press conference, the FDA explained the results of its analysis and its conclusion that there have been infrequent reports of serious adverse events associated with potential spread of product from the site of injection and that the risk is greatest in children treated for juvenile cerebral palsy but also in adults treated for spasticity or cervical dystonia who have underlying conditions that would predispose them to these symptoms.
XEOMIN is FDA approved for the treatment of cervical dystonia in adults, to decrease the severity of abnormal head position and neck pain in both botulinum toxin-naive and previously treated patients, and blepharospasm in adults who have been previously treated with Botox[R] (onabotulinumtoxinA).
This was the first multicenter study to confirm patient safety and efficacy of escalating treatment doses of 10,000 Units, 12,500 Units, and 15,000 Units of Botulinum Toxin Type B in patients with cervical dystonia (CD).
Ipsen's abobotulinumtoxinA approved simultaneously for the treatment of cervical dystonia and glabellar lines under a single trade name, DYSPORT(TM)
Food and Drug Administration (FDA) approved XEOMIN in July 2010 for the treatment of cervical dystonia in adults, to decrease the severity of abnormal head position and neck pain in both botulinum toxin-naive and previously treated patients, and blepharospasm in adults who have been previously treated with Botox[sup.
Food and Drug Administration (FDA) has conditioned its approval of DYSPORT([R]) (abobotulinumtoxinA) for the treatment of cervical dystonia and glabellar lines on their commitment to adopt a Risk Evaluation and Mitigation Strategies (REMS) program.
Table 20: Efficacy Outcomes of the Phase III Cervical Dystonia Study 36
Tokyo, Japan have entered into a commercialization agreement for NeuroBloc(R) (Botulinum Toxin Type B) Injectable Solution, a purified formulation of the neurotoxin produced by the bacterium Clostridium botulinum for treatment of cervical dystonia (CD).
The application, submitted by the Group in late 2007, seeks approval to market Dysport([R])for the treatment of cervical dystonia.
NeuroBloc(R) was approved for Cervical Dystonia through the centralized procedure by the European Medicines Evaluation Agency (EMEA) in January 2001 and has been made available in eight European countries so far.
BOTOX([R]) is approved for the treatment of cervical dystonia in adults to decrease the severity of abnormal head position and neck pain associated with cervical dystonia.